Cargando…
Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795626/ https://www.ncbi.nlm.nih.gov/pubmed/36577974 http://dx.doi.org/10.1186/s12943-022-01702-w |
| _version_ | 1784860301270712320 |
|---|---|
| author | Zhang, Jia-Xing Xu, Yi Gao, Ying Chen, Cui Zheng, Zhou-San Yun, Miao Weng, Hui-Wen Xie, Dan Ye, Sheng |
| author_facet | Zhang, Jia-Xing Xu, Yi Gao, Ying Chen, Cui Zheng, Zhou-San Yun, Miao Weng, Hui-Wen Xie, Dan Ye, Sheng |
| author_sort | Zhang, Jia-Xing |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9795626 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97956262022-12-29 Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway Zhang, Jia-Xing Xu, Yi Gao, Ying Chen, Cui Zheng, Zhou-San Yun, Miao Weng, Hui-Wen Xie, Dan Ye, Sheng Mol Cancer Retraction Note BioMed Central 2022-12-28 /pmc/articles/PMC9795626/ /pubmed/36577974 http://dx.doi.org/10.1186/s12943-022-01702-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Retraction Note Zhang, Jia-Xing Xu, Yi Gao, Ying Chen, Cui Zheng, Zhou-San Yun, Miao Weng, Hui-Wen Xie, Dan Ye, Sheng Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway |
| title | Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway |
| title_full | Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway |
| title_fullStr | Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway |
| title_full_unstemmed | Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway |
| title_short | Retraction Note: Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway |
| title_sort | retraction note: decreased expression of mir-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of slc34a2 and raf/mek/erk pathway |
| topic | Retraction Note |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795626/ https://www.ncbi.nlm.nih.gov/pubmed/36577974 http://dx.doi.org/10.1186/s12943-022-01702-w |
| work_keys_str_mv | AT zhangjiaxing retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT xuyi retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT gaoying retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT chencui retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT zhengzhousan retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT yunmiao retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT wenghuiwen retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT xiedan retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway AT yesheng retractionnotedecreasedexpressionofmir939contributestochemoresistanceandmetastasisofgastriccancerviadysregulationofslc34a2andrafmekerkpathway |